Skip to Content

MainStay WMC Value B MAPBX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 19.98  /  +0.50 %
  • Total Assets 967.0 Mil
  • Adj. Expense Ratio
    2.050%
  • Expense Ratio 2.050%
  • Distribution Fee Level High
  • Share Class Type
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Closed
  • TTM Yield 1.18%
  • Turnover 29%

USD | NAV as of May 07, 2024 | 1-Day Return as of May 07, 2024, 10:22 PM GMT+0

Morningstar’s Analysis MAPBX

Will MAPBX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit MainStay WMC Value B to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MAPBX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

4.09 41.1 Mil
Financial Services

Merck & Co Inc

2.98 30.0 Mil
Healthcare

Johnson & Johnson

2.90 29.2 Mil
Healthcare

Cisco Systems Inc

2.47 24.8 Mil
Technology

Elevance Health Inc

2.10 21.1 Mil
Healthcare

Pfizer Inc

2.07 20.9 Mil
Healthcare

Phillips 66

1.97 19.8 Mil
Energy

American International Group Inc

1.94 19.5 Mil
Financial Services

M&T Bank Corp

1.91 19.2 Mil
Financial Services

UnitedHealth Group Inc

1.89 19.0 Mil
Healthcare